Ixazomib Maintenance Study in Patients With AL Amyloidosis | oneAMYLOIDOSISvoice

Ixazomib Maintenance Study in Patients With AL Amyloidosis

key information

study id #: NCT03618537

condition: AL Amyloidosis

status: Recruiting


The purpose of this study is to learn if Ixazomib maintenance treatment (chemotherapy) works to control the disease. Through this study, the investigators hope to learn more about ways to prevent or delay relapse of AL Amyloidosis.

intervention: Ixazomib, Dexamethasone

results: https://clinicaltrials.gov/ct2/show/results/NCT03618537

last updated: September 17, 2021

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.